title: Spindle cell squamous carcinoma during BRAF inhibitor therapy for advanced melanoma: an aggressive secondary neoplasm of undetermined biologic potential.
authors.forename: Daniel N
authors.initials: DN
authors.lastname: Cohen
authors.forename: Wilfred A
authors.initials: WA
authors.lastname: Lumbang
authors.forename: Alan S
authors.initials: AS
authors.lastname: Boyd
authors.forename: Jeffrey A
authors.initials: JA
authors.lastname: Sosman
authors.forename: Jeffrey P
authors.initials: JP
authors.lastname: Zwerner
mesh_terms: D001707:Biopsy, Needle; D002294:Carcinoma, Squamous Cell / Q000139:chemically induced* / Q000473:pathology; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007150:Immunohistochemistry; D008545:Melanoma / Q000188:drug therapy* / Q000473:pathology; D008875:Middle Aged; D009361:Neoplasm Invasiveness / Q000473:pathology; D009367:Neoplasm Staging; D016609:Neoplasms, Second Primary / Q000139:chemically induced* / Q000473:pathology; D048493:Proto-Oncogene Proteins B-raf / Q000009:adverse effects* / Q000037:antagonists & inhibitors* / Q000600:supply & distribution; D018570:Risk Assessment; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology; D028761:Withholding Treatment
chemical_list: D048493:Proto-Oncogene Proteins B-raf